Bio-Thera Solutions, Ltd announced positive Phase 1 clinical data for BAT8006 as part of a presentation of the clinical results of a Phase 1 dose escalation study evaluating the safety and efficacy of BAT8006 at the Bethune Obstetrics and Gynecology Forum in China.
